BRD2 and depressive symptom measurement: A recent meta-analysis of hypothalamic-pituitary–gonadal dysregulation in depression raised the caveat that new LH and FSH assays with greater sensitivity and improved quality control should be used to reassess the role of gonadotropin secretion  in depression.